Source: MBCV report 2018
The number of newly-diagnosed chronic lymphocytic leukemia (CLL) patients every year in South Korea is approximately 60 individuals. 20
Multiple myeloma is a blood cancer that affects about 6,500 people in South Korea with more than 80% of patients over the age of 50. 21
Most patients experience a relapse or resistance to existing treatments with the average survival rate for these patients being about 5.1 months. 21
The incidence of multiple myeloma (MM) in South Korea has doubled over a 10-year period and based on recent national cancer registry date increase was 10 times compared with MM incidence of 20 years ago. 22